Webinar

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?

Format: External webinar | Document type: Webinar

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
The FDA recently authorized a level C qualified health claim for high-amylose maize resistant starch and a reduced risk of type 2 diabetes. The CDC reports that 1 in 3 American adults have prediabetes and are at risk for developing type 2 diabetes1—with 60% of consumers interested in buying foods that help them “reduce the risk of type 2 diabetes”2. Learn about this qualified health claim, and find out how HI-MAIZE® resistant starch can help you create innovative products.                    1 Click here for CDC reference                    2 Ingredion proprietary consumer research

Speakers

Maria Stewart, PhD Maria Stewart, PhD Clinical Research Lead, Global Nutrition R&D
Ingredion

Santiago Vega, MBA Santiago Vega, MBA Senior Marketing Manager, Nutrition North America
Ingredion

Latest content from Ingredion

The business of clean label

Content provided by Ingredion

The business of clean label

Clean label is an established trend which continues to guide new food and beverage development and reformulation. The market is estimated to be worth over $50bn (€44.8 bn) globally by 2024 , as manufacturers meet continuing consumer demand for delicious,...

Supplier info centre